Search research articles
Contact Us
Filters
Showing results (81-90 of 140) with videos related to
Page
of 14
Sort By:
Cell Death and Differentiation
|
April 5, 2022
Disease-associated KBTBD4 mutations in medulloblastoma elicit neomorphic ubiquitylation activity to promote CoREST degradation
Zhuoyao Chen, Rafael M Ioris, Stacey Richardson, et al.
Cancer
|
February 27, 2010
hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer
Harriet E Gee, Carme Camps, Francesca M Buffa, et al.
Journal of the National Cancer Institute. Monographs
|
November 2, 2011
Assessing early therapeutic response to bevacizumab in primary breast cancer using magnetic resonance imaging and gene expression profiles
Shaveta Mehta, Nicholas P Hughes, Francesca M Buffa, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
December 20, 2022
WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanoma
Nicholas Coupe, Lina Guo, Esther Bridges, et al.
Cancer & Metabolism
|
July 11, 2020
Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cells
Masahiro Kawashima, Karim Bensaad, Christos E Zois, et al.
Molecular Cancer Research : MCR
|
August 5, 2021
ADGRL4/ELTD1 Expression in Breast Cancer Cells Induces Vascular Normalization and Immune Suppression
Helen Sheldon, Esther Bridges, Ildefonso Silva, et al.
Cancer & Metabolism
|
August 14, 2020
Correction to: Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cells
Masahiro Kawashima, Karim Bensaad, Christos E Zois, et al.
British Journal of Cancer
|
November 6, 2008
Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types
M H W Starmans, B Krishnapuram, H Steck, et al.
Cancer Biology & Medicine
|
September 14, 2019
Identification of anticancer drugs to radiosensitise <i>BRAF</i>-wild-type and mutant colorectal cancer
Rebecca Carter, Azadeh Cheraghchi-Bashi, Adam Westhorpe, et al.
Molecular Cell
|
January 4, 2011
miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors
Patryk Moskwa, Francesca M Buffa, Yunfeng Pan, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 140) with videos related to
Sort By:
Page
of 14
Cell Death and Differentiation
|
April 5, 2022
Disease-associated KBTBD4 mutations in medulloblastoma elicit neomorphic ubiquitylation activity to promote CoREST degradation
Zhuoyao Chen, Rafael M Ioris, Stacey Richardson, et al.
Cancer
|
February 27, 2010
hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer
Harriet E Gee, Carme Camps, Francesca M Buffa, et al.
Journal of the National Cancer Institute. Monographs
|
November 2, 2011
Assessing early therapeutic response to bevacizumab in primary breast cancer using magnetic resonance imaging and gene expression profiles
Shaveta Mehta, Nicholas P Hughes, Francesca M Buffa, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
December 20, 2022
WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanoma
Nicholas Coupe, Lina Guo, Esther Bridges, et al.
Cancer & Metabolism
|
July 11, 2020
Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cells
Masahiro Kawashima, Karim Bensaad, Christos E Zois, et al.
Molecular Cancer Research : MCR
|
August 5, 2021
ADGRL4/ELTD1 Expression in Breast Cancer Cells Induces Vascular Normalization and Immune Suppression
Helen Sheldon, Esther Bridges, Ildefonso Silva, et al.
Cancer & Metabolism
|
August 14, 2020
Correction to: Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cells
Masahiro Kawashima, Karim Bensaad, Christos E Zois, et al.
British Journal of Cancer
|
November 6, 2008
Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types
M H W Starmans, B Krishnapuram, H Steck, et al.
Cancer Biology & Medicine
|
September 14, 2019
Identification of anticancer drugs to radiosensitise <i>BRAF</i>-wild-type and mutant colorectal cancer
Rebecca Carter, Azadeh Cheraghchi-Bashi, Adam Westhorpe, et al.
Molecular Cell
|
January 4, 2011
miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors
Patryk Moskwa, Francesca M Buffa, Yunfeng Pan, et al.
Page
of 14